Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B C Lund

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Pharmacotherapy|February 24, 2001
Visual disturbance associated with celecoxibB C Lund, R F Neiman
Expert Opinion on Pharmacotherapy|March 16, 2001
Olanzapine: an atypical antipsychotic for schizophreniaB C Lund, P J Perry
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|October 24, 1998
Strategies in the treatment of penicillin-resistant Streptococcus pneumoniaeB C Lund, E J Ernst, M E Klepser
The Annals of Pharmacotherapy|November 29, 2001
Peripheral edema associated with mirtazapineE C Kutscher, B C Lund, B A Hartman
Pharmacotherapy|November 23, 2001
Failed challenge with quetiapine after neuroleptic malignant syndrome with conventional antipsychoticsC D Hatch, B C Lund, P J Perry
The American Journal of Psychiatry|September 5, 2001
Treating depression in schizophreniaB C Lund, P J Perry, D D Miller
Pharmacotherapy|December 22, 1999
Treatment of Parkinson's disease with ropinirole after pergolide-induced retroperitoneal fibrosisB C Lund, R F Neiman, P J Perry
Pharmacotherapy|June 13, 2001
Ziprasidone, a new atypical antipsychotic drugR M Carnahan, B C Lund, P J Perry
Journal of Clinical Psychopharmacology|February 24, 2001
Olanzapine plasma concentrations and clinical response: acute phase results of the North American Olanzapine TrialP J Perry, B C Lund, T Sanger, et al.
Pharmacotherapy|August 24, 1999
Testosterone and andropause: the feasibility of testosterone replacement therapy in elderly menB C Lund, K A Bever-Stille, P J Perry
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Pharmacotherapy|February 24, 2001
Visual disturbance associated with celecoxibB C Lund, R F Neiman
Expert Opinion on Pharmacotherapy|March 16, 2001
Olanzapine: an atypical antipsychotic for schizophreniaB C Lund, P J Perry
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|October 24, 1998
Strategies in the treatment of penicillin-resistant Streptococcus pneumoniaeB C Lund, E J Ernst, M E Klepser
The Annals of Pharmacotherapy|November 29, 2001
Peripheral edema associated with mirtazapineE C Kutscher, B C Lund, B A Hartman
Pharmacotherapy|November 23, 2001
Failed challenge with quetiapine after neuroleptic malignant syndrome with conventional antipsychoticsC D Hatch, B C Lund, P J Perry
The American Journal of Psychiatry|September 5, 2001
Treating depression in schizophreniaB C Lund, P J Perry, D D Miller
Pharmacotherapy|December 22, 1999
Treatment of Parkinson's disease with ropinirole after pergolide-induced retroperitoneal fibrosisB C Lund, R F Neiman, P J Perry
Pharmacotherapy|June 13, 2001
Ziprasidone, a new atypical antipsychotic drugR M Carnahan, B C Lund, P J Perry
Journal of Clinical Psychopharmacology|February 24, 2001
Olanzapine plasma concentrations and clinical response: acute phase results of the North American Olanzapine TrialP J Perry, B C Lund, T Sanger, et al.
Pharmacotherapy|August 24, 1999
Testosterone and andropause: the feasibility of testosterone replacement therapy in elderly menB C Lund, K A Bever-Stille, P J Perry
Pageof 2